Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Harte Hanks (HHS) Revenue (2016 - 2025)

Harte Hanks has reported Revenue over the past 16 years, most recently at $39.9 million for Q4 2025.

  • Quarterly Revenue fell 15.43% to $39.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $159.6 million through Dec 2025, down 13.86% year-over-year, with the annual reading at $159.6 million for FY2025, 13.86% down from the prior year.
  • Revenue was $39.9 million for Q4 2025 at Harte Hanks, up from $39.5 million in the prior quarter.
  • Over five years, Revenue peaked at $54.8 million in Q4 2022 and troughed at $38.6 million in Q2 2025.
  • The 5-year median for Revenue is $47.4 million (2024), against an average of $46.9 million.
  • Year-over-year, Revenue grew 18.41% in 2021 and then decreased 17.03% in 2025.
  • A 5-year view of Revenue shows it stood at $52.0 million in 2021, then grew by 5.37% to $54.8 million in 2022, then dropped by 9.65% to $49.5 million in 2023, then dropped by 4.77% to $47.1 million in 2024, then dropped by 15.43% to $39.9 million in 2025.
  • Per Business Quant, the three most recent readings for HHS's Revenue are $39.9 million (Q4 2025), $39.5 million (Q3 2025), and $38.6 million (Q2 2025).